Daniel Arndt
Neurology with Special Qualifications in Child Neurology · West Bloomfield, MINPI 1245499961
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $52,826 of the $61,949 with a category attached, or 85.3%. 19 manufacturers reported payments, led by Mallinckrodt Enterprises LLC at 49.9% of the total. Reporting peaked in 2019 at $34,676 and has fallen 72.7% since, to $9,462 in 2025. Among neurology with special qualifications in child neurology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $445.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Enterprises LLC$31K
- Livanova USA, Inc.$23K
- Mallinckrodt Hospital Products Inc.$6K
- Biomarin Pharmaceutical Inc.$1K
- UCB, Inc.$471
- Jazz Pharmaceuticals Inc.$285
- plus $777 from 13 others
Across 11 payments — averaging $2414.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mallinckrodt Hospital Products Inc.$10K
- Zogenix Inc.$8K
- GW Research Limited$7K
- UCB SA$1K
- UCB, Inc.$800
What the payments were for
- Consulting fees$1,7003%
- Speaking & faculty fees$52,82685%
- Travel & lodging$4,2337%
- Food & beverage$3,1785%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Enterprises LLC | 36 | $30,919 |
| Livanova USA, Inc. | 43 | $22,726 |
| Mallinckrodt Hospital Products Inc. | 2 | $5,700 |
| Biomarin Pharmaceutical Inc. | 8 | $1,072 |
| UCB, Inc. | 19 | $471 |
| Jazz Pharmaceuticals Inc. | 4 | $285 |
| Neurelis, Inc. | 8 | $167 |
| Biocodex, Inc. | 1 | $130 |
| Sunovion Pharmaceuticals Inc. | 1 | $122 |
| Otter Pharmaceuticals, LLC | 3 | $71 |
| Acadia Pharmaceuticals Inc | 2 | $54 |
| Catalyst Pharmaceuticals, Inc. | 2 | $48 |
| Aucta Pharmaceuticals, Inc. | 3 | $45 |
| Upsher-smith Laboratories LLC | 2 | $43 |
| Medtronic | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| AstraZeneca | 1 | $20 |
| Intrabio Inc | 1 | $16 |
| Zogenix Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTHAR$36,104
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$12,425
- VNS Therapy$9,886
- Brineura$648
- DIACOMIT$130
- APTIOM$122
- Epidiolex$122
- Fintepla$115
How this compares
$61,949 in reported general payments places this provider in the 95th percentile of 62 neurology with special qualifications in child neurology providers in Michigan.
See all neurology with special qualifications in child neurology providers in Michigan →
Other neurology with special qualifications in child neurology in West Bloomfield
- Suad KhalilEast Lansing$146K
- Gyula AcsadiDetroit$86K
- Michelle FigueroaDetroit$57K
- Christopher AllenSaginaw$38K
- Kheir Al-ZouhayliTroy$32K
- Jena KruegerGrand Rapids$22K
- Seth DevriesGrand Rapids$14K
- Aimee LuatDetroit$12K
- Danielle NolanRoyal Oak$7K
- Eishi AsanoDetroit$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.